These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17199317)

  • 21. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
    Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species differences in platelet aggregation induced by platelet-activating factor (PAF).
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Ou M; Mori T
    Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):663-5. PubMed ID: 1294855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation.
    Di Braccio M; Roma G; Grossi GC; Leoncini G; Maresca M
    Farmaco; 1992 Jan; 47(1):77-90. PubMed ID: 1616579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
    Karantonis HC; Fragopoulou E; Antonopoulou S; Rementzis J; Phenekos C; Demopoulos CA
    Diabetes Res Clin Pract; 2006 Apr; 72(1):33-41. PubMed ID: 16236380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
    Kertscher HP; Ostermann G
    Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
    Wang XD; Bian RL
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
    Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
    J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPLC analysis of oleuropein, hydroxytyrosol, and tyrosol in stems and roots of Olea europaea L. cv. Picual during ripening.
    Ortega-García F; Peragón J
    J Sci Food Agric; 2010 Oct; 90(13):2295-300. PubMed ID: 20648529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. bark.
    Olas B; Wachowicz B; Stochmal A; Oleszek W
    Platelets; 2002 May; 13(3):167-73. PubMed ID: 12180499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
    Karantonis HC; Antonopoulou S; Perrea DN; Sokolis DP; Theocharis SE; Kavantzas N; Iliopoulos DG; Demopoulos CA
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):174-85. PubMed ID: 16580585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
    Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
    Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals.
    Carluccio MA; Siculella L; Ancora MA; Massaro M; Scoditti E; Storelli C; Visioli F; Distante A; De Caterina R
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):622-9. PubMed ID: 12615669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologically active lipids with antiatherogenic properties from white wine and must.
    Fragopoulou E; Antonopoulou S; Demopoulos CA
    J Agric Food Chem; 2002 Apr; 50(9):2684-94. PubMed ID: 11958642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.